Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Göğüs Hastalıkları
Articles 56 YÖKSİS 56 · OpenAlex 0 Total citations 628 h-index 12 · OpenAlex Q1 articles 12 Scopus · WoS Q1 8 Best field rank #5,704 / 39,749 Main field · top 14.4% Co-authors 1 0 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 32 + YÖKSİS · co-author record: 11
h-index 12 Percentile in Türkiye: 87 #81 of 889 at their university by h-index
i10-index
17
Total citations
628
Top 15% in Türkiye
Per article
14.6
FWCI
1.46
1.00 = world average
World top 1%
1
World top 10%
7
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 11 articles (230 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
1
With an akaturk profile
0
Turkish institutions
0
Co-authored works
%38

Academic co-authors 0

No co-author with an akaturk profile.

National collaboration 0 institutions

No joint work with another Turkish university.

Other co-authors (incl. international) 1

ÖZTÜRK AYŞE BİLGE 21

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 0 articles
OpenAlex citation percentile
Top 1%0
Top 10%5
Avg · n 32 %65.1
Other counts

Scopus (SJR)

  • YÖKSİS rows 35

WoS (JCR)

  • YÖKSİS rows 35

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

56articles

Journals with publications

20 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index
0articles

Article list

  1. 2026 Identifying future risk factors of uncontrolled asthma control: the TAAR study perspective JOURNAL OF ASTHMA DOI 10.1080/02770903.2025.2592244 YÖKSİS SJR Q2 JCR Q3 OpenAlex 34.3%
  2. 2026 ASTHMA PHENOTYPES AND COMORBID DISEASES Int Arch Allergy Immunol . DOI 10.1159/000552377 YÖKSİS SJR Q2 JCR Q3
  3. 2026 Effect of low salicylate diet and blood salicylate level on the symptom control of chronic spontaneous urticaria Frontiers in Allergy DOI 10.3389/falgy.2025.1687600. YÖKSİS SJR Q2 JCR Q2 OpenAlex 44.4%
  4. 2026 Early Detection of Lower Adherence to Long‐Term e‐Diary Recording: A Checkpoint to Target Early Educational Intervention in Seasonal Allergic Rhinitis? Clinical & Experimental Allergy DOI 10.1111/cea.70203 YÖKSİS SJR Q2 JCR Q1
  5. 2026 Classification of Seasonal Allergic Rhinitis Patients by Prospective Patient-Recorded Symptoms: The @IT.2020 Project Allergy DOI 10.1111/all.70447 YÖKSİS SJR Q1 JCR Q1
  6. 2025 Asthma patients with obesity have a unique phenotype: a subanalysis of the Turkish adult asthma registry Journal of Asthma DOI 10.1080/02770903.2025.2466182 YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.0%
  7. 2025 What Does Radiologic Assessment Contribute to Asthma: A Subanalysis of the Turkish Adult Asthma Registry Bratislava Medical Journal DOI 10.1007/s44411-025-00104-w YÖKSİS SJR Q3 JCR Q2 OpenAlex 8.7%
  8. 2025 Distinct Characteristics of Asthma Overlap Phenotypes: Insights from the Turkish Adult Asthma Registry Journal of Asthma DOI 10.1080/02770903.2025.2493134 YÖKSİS SJR Q2 JCR Q3 OpenAlex 8.2%
  9. 2025 Trends in prescribing montelukast in patients with asthma in real-life: Results from the Turkish adult asthma registry Allergol Immunopathol (Madr). DOI 10.15586/aei.v53i1.1183 YÖKSİS SJR Q3 JCR Q3 OpenAlex 57.8%
  10. 2025 Socioeconomic status has direct impact on asthma control: Turkish adult asthma registry Clinical and Translational Allergy DOI 10.1002/clt2.70018 YÖKSİS SJR Q1 JCR Q2 OpenAlex 74.7%
  11. 2025 Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry Respiratory Medicine DOI 10.1016/j.rmed.2024.107883 YÖKSİS SJR Q1 JCR Q2 OpenAlex 65.6%
  12. 2024 Clinical features, severity, and immunological changes during venom immunotherapy in children and adults Allergy and Asthma Proceedings DOI 10.2500/aap.2024.45.240017 YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.2%
  13. 2024 Inhaler Steroid Use Changes Oral and Airway Bacterial and Fungal Microbiome Profile in Asthma Patients. International archives of allergy and immunology DOI 10.1159/000531866 YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.6%
  14. 2023 Characteristics of asthma in an older adult population according to sex and control level: why are asthma symptoms in older women not well-controlled? The Journal of asthma : official journal of the Association for the Care of Asthma DOI 10.1080/02770903.2023.2293062 YÖKSİS SJR Q2 JCR Q3 OpenAlex 61.6%
  15. 2023 Picturing asthma in Turkey: results from the Turkish adult asthma registry. The Journal of asthma : official journal of the Association for the Care of Asthma DOI 10.1080/02770903.2023.2206902 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 90.0%
  16. 2022 Functionality of natural killer cells in obese asthma phenotypes. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology DOI 10.1111/cea.14136 YÖKSİS SJR Q2 JCR Q1 OpenAlex 48.0%
  17. 2021 Bronchoscopy during the COVID-19 pandemic: A survey study. Turk gogus kalp damar cerrahisi dergisi DOI 10.5606/tgkdc.dergisi.2021.20351 YÖKSİS SJR Q3 JCR Q4 OpenAlex 74.7%
  18. 2021 Cumulative Pollen Concentration Curves for Pollen Allergy Diagnosis Journal of Investigational Allergology and Clinical Immunology DOI 10.18176/jiaci.0646 YÖKSİS SJR Q3 JCR Q1 OpenAlex 66.6%
  19. 2021 Immune profiling after minimally invasive lobectomy. Interactive cardiovascular and thoracic surgery DOI 10.1093/icvts/ivaa296 YÖKSİS SJR Q2 JCR Q3 OpenAlex 75.6%
  20. 2021 COVID-19, Severe Asthma and Omalizumab Therapy: A Case-Based Inquiry into Associations, Management, and the Possibility of a Better Outcome. Turkish thoracic journal DOI 10.5152/TurkThoracJ.2021.20329 YÖKSİS OpenAlex 17.5%

← Back to academicians